Results of fractionated TBI prior to bone marrow transplantation in standard risk leukaemia at Marseille.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 2247638.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
One hundred and six patients with standard risk leukaemia were given fractionated TBI prior to allogeneic (72 cases, 27 of whom were T-depleted) or autologous (34 cases) bone marrow transplantation (BMT). Disease free survival at 5 years is 68% for allogeneic non T-depleted BMT and 33% for T-depleted BMT. Deaths are related to relapse, GVHD, infections, pneumonitis, encephalitis, VOD, AIDS, rejection.
Medical subject headings
- Bone Marrow Transplantation
- Leukemia
- Whole-Body Irradiation